The muscle that prevents stomach acid from backing up and entering the esophagus and throat is the esophageal sphincter. Stomach acid that does backup into the throat is acid reflux. Some acid reflux medicine such as antihistamines, birth control pills, antispasmodics, heart medications and asthma medications can decrease the strength of the lower esophageal muscles. This however, happens over time, not right away. When the esophageal muscle weakens, this problem occurs more frequently.
Acid reflux medicine should be taken as prescribed in order for it to work properly. If you start feeling better after taking your medicine, do not stop taking it. Otherwise, your symptoms just may reappear. If your symptoms remain untreated then it can lead to a more serious condition known as gastoesophageal reflux disease or GERD.
Many people do not inform their doctor that they have stopped taking their reflux medication until the condition becomes very serious and thus they then require more intensive treatment options. Thus, if you are taking heartburn medications do not stop taking it if your symptoms subside.
Mild reflux is treated with antacids. A more persistent form is treated with stronger antacids such as Mylanta II, Maalox II and Riopan. A greater number of people than the tablet form prefer liquid forms of acid reflux medicine. Antacid medication is to be taken thirty to sixty minutes after meals and before going to bed.
Certain types of foods should be avoided if you have this condition. These particular foods have chemicals that trigger the onset of this stomach issue. Foods such as chocolate, peppermint, tomatoes and products made from tomatoes should be avoided since they cause heartburn and acid reflux.
Vonseca® is the first full range Generic of Vonoprazan In Egypt
As per its commitment to offer the latest treatment for the Egyptian’s patients., in Jan 2022 Zeta Pharma was the first Egyptian pharmaceutical company to introduce two concentrations of 10mg and 20 mg of vonoprazan in the Egyptian market through its brand Vonseca.®
? is a first-in-class potassium-competitive acid blocker. It was approved in the Japanese market in February 2015.
Vonoprazan is used in form of the fumarate for the treatment of gastroduodenal ulcer (including some drug-induced peptic ulcers) and reflux esophagitis, and can be combined with antibiotics for the eradication of Helicobacter pylori.
The (?) has approved 2 ?-based medications for the treatment of Helicobacter pylori (H. pylori) infection.
The approval of ? treatment regimens offers physicians and patients 2 therapeutic options that showed superior eradication rates compared to proton pump inhibitor-based (PPI) lansoprazole triple therapy in the overall patient population in a pivotal trial.
? belongs to a class of products known as PCAB, or potassium-competitive acid blockers. By blocking the potassium-binding site of gastric hydrogen potassium ATPase (also known as the proton pump), which is the enzyme largely responsible for acidification of the stomach, it’s designed to overcome many of the perceived weaknesses of traditional proton pump inhibitor therapy.
If you need any kind of information on this article related topic click here: Vonaspire